MDDI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Biomaterials and the Future of Medical Devices

Fairly recently, I had a phone conversation with Marc Hendriks, R&D and technology director at DSM Biomedical. Hendriks had just announced over Twitter that he had recently given a guest lecture at the University of California, Berkeley and I was curious about the contents of his presentation.

Marc HendriksRecently, I had a phone conversation with Marc Hendriks, R&D and technology director at DSM Biomedical. Hendriks had just announced over Twitter that he had recently given a guest lecture at the University of California, Berkeley and I was curious about the contents of his presentation.

While giving me a summary of his biomaterials lecture over the phone, It was clear that Hendriks, who has a doctorate in chemical engineering and holds 25 U.S. patents, is a real expert on the subject. By the end of our conversation, I had an invitation to send over a few questions, the answers to which I planned on sharing with our readers. 

The result of that exchange exceded my already high expectations. I present here his in-depth response to each of the four broad questions I asked: 

  1. How do you envision that biomaterials will help address medical applications in the near future and longer term?
  2. Could you explain what you mean when you refer to three generations of biomaterials?
  3. How has biomaterials research transformed orthopedics and cardiovascular devices?
  4. Could you give us an overview of biomaterials’ current and likely future role in tissue engineering?

Brian Buntz

Filed Under
500 characters remaining